DK424988D0 - SPECIFIC EXPRESSION -SCRETION ANTIGENS OF TOXOPLASMA GONDII, EXPRESSION PRODUCTS THEREOF, PROCEDURES FOR PRODUCING THEREOF, AND DIAGNOSTIC AND PROPHYLACTIC APPLICATIONS THEREOF - Google Patents
SPECIFIC EXPRESSION -SCRETION ANTIGENS OF TOXOPLASMA GONDII, EXPRESSION PRODUCTS THEREOF, PROCEDURES FOR PRODUCING THEREOF, AND DIAGNOSTIC AND PROPHYLACTIC APPLICATIONS THEREOFInfo
- Publication number
- DK424988D0 DK424988D0 DK424988A DK424988A DK424988D0 DK 424988 D0 DK424988 D0 DK 424988D0 DK 424988 A DK424988 A DK 424988A DK 424988 A DK424988 A DK 424988A DK 424988 D0 DK424988 D0 DK 424988D0
- Authority
- DK
- Denmark
- Prior art keywords
- antigens
- toxoplasma gondii
- scretion
- diagnostic
- procedures
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 6
- 102000036639 antigens Human genes 0.000 title abstract 6
- 108091007433 antigens Proteins 0.000 title abstract 6
- 241000223997 Toxoplasma gondii Species 0.000 title abstract 4
- 230000014509 gene expression Effects 0.000 title 2
- 238000000034 method Methods 0.000 title 1
- 230000000069 prophylactic effect Effects 0.000 title 1
- 201000005485 Toxoplasmosis Diseases 0.000 abstract 3
- 239000000470 constituent Substances 0.000 abstract 2
- 210000000059 tachyzoite Anatomy 0.000 abstract 2
- 210000000061 bradyzoite Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/45—Toxoplasma
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Toxoplasma gondii (TG) antigens consisting of excretion-secretion (ES) antigens common to the tachyzoites and the bradyzoites of TG, and translation products of mRNA of tachyzoites carrying the epitopes recognised by the abovementioned ES antigens. Polyclonal and monoclonal antibodies capable of conferring significant protection against toxoplasmosis, in the form of vaccines in particular. Therapeutic composition for the treatment of toxoplasmosis, the active constituents of which are the abovementioned ES antigens. Products for the diagnosis of toxoplasmosis, the active constituents of which are the abovementioned ES antigens.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8710891 | 1987-07-31 | ||
FR8710891A FR2618680B1 (en) | 1987-07-31 | 1987-07-31 | TOXOPLASMA GONDII SPECIFIC EXCRETION-SECRETION ANTIGENS, THEIR EXPRESSION PRODUCTS, THE PROCESS FOR OBTAINING SAME AND THEIR DIAGNOSTIC AND PROPHYLACTIC APPLICATIONS |
Publications (3)
Publication Number | Publication Date |
---|---|
DK424988D0 true DK424988D0 (en) | 1988-07-29 |
DK424988A DK424988A (en) | 1989-02-01 |
DK171259B1 DK171259B1 (en) | 1996-08-12 |
Family
ID=9353771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK424988A DK171259B1 (en) | 1987-07-31 | 1988-07-29 | Specific excretion-secretion antigens of Toxoplasma gondii, their translational products, their method of preparation and their diagnostic applications |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0301961B1 (en) |
JP (1) | JPH01131125A (en) |
KR (1) | KR890001588A (en) |
AT (1) | ATE96675T1 (en) |
AU (1) | AU625171B2 (en) |
DE (1) | DE3885365T2 (en) |
DK (1) | DK171259B1 (en) |
ES (1) | ES2061705T3 (en) |
FR (1) | FR2618680B1 (en) |
PT (1) | PT88157B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3940598A1 (en) * | 1989-12-08 | 1991-06-13 | Behringwerke Ag | TOXOPLASMA GONDII-ANTIGENE, THEIR PRODUCTION AND USE |
DE68926658T2 (en) * | 1988-03-09 | 1996-11-28 | Univ Leland Stanford Junior | DIAGNOSTIC GENES FOR DETECTING TOXOPLASMOSIS |
JP2759457B2 (en) * | 1988-05-13 | 1998-05-28 | 住友製薬株式会社 | Antitumor protein |
JPH02261382A (en) * | 1989-04-03 | 1990-10-24 | Mochida Pharmaceut Co Ltd | Novel dna sequence originated from toxoplasma and protein coded therewith |
US5215917A (en) * | 1989-11-03 | 1993-06-01 | Research Institute Of Palo Alto Medical Foundation | Nucleotide sequence encoding the Toxoplasma gondii P22 gene |
EP0542843A4 (en) * | 1990-08-10 | 1994-07-06 | Univ Southern Australia | Cloning and expression of toxoplasma antigens and use of recombinant antigens |
GB9027728D0 (en) * | 1990-12-20 | 1991-02-13 | Smithkline Beecham Biolog | Novel protein |
ZA958366B (en) * | 1994-10-06 | 1996-04-24 | Akzo Nobel Nv | New toxoplasma gondii antigens |
FR2842813B1 (en) * | 2002-07-26 | 2007-06-01 | Bio Veto Tests Bvt | ANTI-ANTIGENIC ISOTYPE ANTIBODIES FOR EXCRETION SECRETION OF PROMASTIGOTES OR AMASTIGOTS OF Leishmania sp |
SI1856159T1 (en) | 2005-03-08 | 2010-08-31 | Sigma Tau Ind Farmaceuti | Chimeric recombinant antigens of toxoplasma gondii |
KR100818779B1 (en) * | 2007-05-22 | 2008-04-02 | 에이취디알 주식회사 | Trichomonas vaginalis diagnostic kit |
MY197339A (en) * | 2010-07-07 | 2023-06-13 | Univ Sains Malaysia | Uses of biological compounds from toxoplasma sp and related compounds |
CN115287257B (en) * | 2022-09-29 | 2022-12-13 | 广东医科大学附属医院 | An osteogenic induced differentiation culture medium based on toxoplasma exocrine protein preparation method and osteogenic induced differentiation method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2518407A1 (en) * | 1981-12-17 | 1983-06-24 | Merieux Inst | NOVEL ANTIGEN FOR THE RESEARCH OF TOXOPLASMIC IMMUNITY AND ITS PREPARATION METHOD |
FR2564731B1 (en) * | 1984-05-28 | 1986-10-10 | Ambroise Thomas Pierre | NOVEL TOXOPLASMIC EXO-ANTIGENIC FRACTIONS, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE RESEARCH OF TOXOPLASMIC IMMUNITY IN MAN BY SKIN TESTS |
JP2759457B2 (en) * | 1988-05-13 | 1998-05-28 | 住友製薬株式会社 | Antitumor protein |
-
1987
- 1987-07-31 FR FR8710891A patent/FR2618680B1/en not_active Expired - Lifetime
-
1988
- 1988-07-26 AU AU20027/88A patent/AU625171B2/en not_active Ceased
- 1988-07-27 EP EP88401948A patent/EP0301961B1/en not_active Expired - Lifetime
- 1988-07-27 DE DE88401948T patent/DE3885365T2/en not_active Expired - Fee Related
- 1988-07-27 AT AT88401948T patent/ATE96675T1/en not_active IP Right Cessation
- 1988-07-27 ES ES88401948T patent/ES2061705T3/en not_active Expired - Lifetime
- 1988-07-29 DK DK424988A patent/DK171259B1/en not_active IP Right Cessation
- 1988-07-29 PT PT88157A patent/PT88157B/en not_active IP Right Cessation
- 1988-07-31 KR KR1019880009809A patent/KR890001588A/en not_active Application Discontinuation
- 1988-08-01 JP JP63192579A patent/JPH01131125A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2618680A1 (en) | 1989-02-03 |
DK171259B1 (en) | 1996-08-12 |
DE3885365D1 (en) | 1993-12-09 |
KR890001588A (en) | 1989-03-27 |
PT88157A (en) | 1989-06-30 |
ATE96675T1 (en) | 1993-11-15 |
ES2061705T3 (en) | 1994-12-16 |
AU2002788A (en) | 1989-02-02 |
FR2618680B1 (en) | 1990-05-11 |
EP0301961B1 (en) | 1993-11-03 |
DE3885365T2 (en) | 1994-05-05 |
AU625171B2 (en) | 1992-07-02 |
DK424988A (en) | 1989-02-01 |
JPH01131125A (en) | 1989-05-24 |
PT88157B (en) | 1995-03-01 |
EP0301961A1 (en) | 1989-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK424988D0 (en) | SPECIFIC EXPRESSION -SCRETION ANTIGENS OF TOXOPLASMA GONDII, EXPRESSION PRODUCTS THEREOF, PROCEDURES FOR PRODUCING THEREOF, AND DIAGNOSTIC AND PROPHYLACTIC APPLICATIONS THEREOF | |
NL300353I1 (en) | Drugs with monoclonal antibodies that are specific to the human epidermal growth factor receptor | |
DK388384D0 (en) | MONOCLONE ANTIBODIES WITH SPECIFICITY FOR MEMBRANE-ASSOCIATED ANTIGENS, THEIR PREPARATION AND USE | |
ATE132197T1 (en) | MONOCLONAL ANTIBODIES | |
DK304087A (en) | HUMANT MONOCLONAL ANTIBODY AGAINST LUMPHADENOPATIA-ASSOCIATED VIRUS | |
IT1207589B (en) | COMPOSITION OF CROSS-PROTECTIVE HUMAN MONOCLONAL ANTIBODIES. | |
Boyce et al. | Physicochemical characterization and monoclonal and polyclonal antibody recognition of Baylisascaris procyonis larval excretory-secretory antigens | |
DK102589A (en) | ANTIGEN RECOGNIZED BY MCA 16-88 | |
ES2000615A6 (en) | Monoclonal antibodies against tumour-associated glycoproteins, process for their preparation and their use. | |
ATE138200T1 (en) | THE ANTIGEN RECOGNIZED BY MCA-28A32 | |
KR890016165A (en) | Monoclonal Antibodies to Pseudomonas aeruginosa, Methods for Making and Uses thereof | |
ES8800052A1 (en) | Anaplasma marginale subunit antigen for vaccination and diagnosis. | |
SE8803062L (en) | SEQUENTIAL POLYPEPTIDES WITH IMMUNOLOGICAL ACTIVITY | |
Smith et al. | Serodiagnosis of human toxocariasis | |
Gill et al. | Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae | |
DK0513565T3 (en) | Monoclonal antibodies against the plasmin-antiplasmin complex, method for their preparation and their use | |
吉原一浩 et al. | Bovine monoclonal antibody specific to Theileria sergenti. | |
Nishihira et al. | Quantitative Studies of the Activities of Anti-Human Tonsil Sera and Anti-Human Spleen Sera against B Lymphocyte | |
ATE95426T1 (en) | HUMAN CARCINOMA-ASSOCIATED ANTIGEN AND ANTIBODIES BINDING TO THIS ANTIGEN. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B1 | Patent granted (law 1993) | ||
PBP | Patent lapsed |